1. Home
  2. AVXL vs CRNT Comparison

AVXL vs CRNT Comparison

Compare AVXL & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$3.13

Market Cap

237.2M

Sector

Health Care

ML Signal

HOLD

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.06

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVXL
CRNT
Founded
2004
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
237.2M
213.6M
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
AVXL
CRNT
Price
$3.13
$2.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$22.00
$3.50
AVG Volume (30 Days)
863.1K
448.0K
Earning Date
05-08-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.11
Revenue Next Year
N/A
$6.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.26
$1.85
52 Week High
$10.40
$3.29

Technical Indicators

Market Signals
Indicator
AVXL
CRNT
Relative Strength Index (RSI) 52.69 36.82
Support Level $2.93 $2.06
Resistance Level $3.53 $2.37
Average True Range (ATR) 0.15 0.08
MACD -0.02 -0.00
Stochastic Oscillator 5.21 8.57

Price Performance

Historical Comparison
AVXL
CRNT

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

Share on Social Networks: